Health · 1 sources covering this

Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending

KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

KFF Health NewsLean L·1h ago
Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Read at KFF Health News →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/1e60589b5fc9ec065992f2c53533c0d1fca902db"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending"></iframe>

Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending

How 1 sources are covering this

Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending

More from Health

Cyclospora outbreaks grow in the Midwest

Nominee for key federal health role has a history of questioning vaccines

STAT+: Roche ends Huntington’s gene-silencing programs

STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more

Reader

Trust & legal

Across the network

How 1 sources are covering this

Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending

More from Health

Cyclospora outbreaks grow in the Midwest

Nominee for key federal health role has a history of questioning vaccines

STAT+: Roche ends Huntington&#8217;s gene-silencing programs

STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more

Reader

Trust & legal

Across the network

STAT+: Roche ends Huntington’s gene-silencing programs